European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting: workshop on risk minimisation measures

  • Email
  • Help

Details

TitleEuropean Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting: workshop on risk minimisation measures
Date16/09/2015 - 16/09/2015
LocationEuropean Medicines Agency, London, UK
SummaryThis is a workshop on risk minimisation measures with representatives from patients’, consumers’ and healthcare professionals’ organisations. An overview of the regulatory environment supporting the development of risk minimisation measures will be provided to participants; In addition, current practices/experience in the implementation and evaluation of the effectiveness of additional risk minimisation measures will be shared, using concrete examples. Participants will also discuss challenges and opportunities posed by the implementation and evaluation of risk minimisation measures in real life clinical practice. Registration by invitation only.

All documents

Name Language First published Last updated
Agenda - European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting: workshop on risk minimisation measures (English only) 2015-08-04 2015-12-14
List of participants of the European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting: workshop on risk minimisation measures (English only) 2015-12-14  
Towards optimising risk minimisation measures: report on European Medicines Agency’s workshop on risk minimisation measures (English only) 2015-12-14  
Presentation - Objectives of the workshop (Guido Rasi) (English only) 2015-12-14  
Presentation - What are risk minimisation measures and why are they imposed (Sabine Straus) (English only) 2015-12-14  
Presentation - PRAC patient representative (Marco Greco) (English only) 2015-12-14  
Presentation - Practical experiences of risk minimisation (Ciara Kirke) (English only) 2015-12-14  
Presentation - How does the EU Regulatory Network communicates about risk minimisation? (Viola Macolić-Šarinić, Juan Garcia-Burgos) (English only) 2015-12-14  
Presentation - Overview of methodologies and studies evaluating risk minimisation measures (Giampiero Mazzaglia) (English only) 2015-12-14  
Presentation - Feasibility and effectiveness of interventions: the valproate case study- EAN-ILAE joint task force (Marianne de Visser) (English only) 2015-12-14  
Presentation - Patient perspectives on monitoring effectiveness of risk minimisation measures in the field of multiple sclerosis (Christoph Thalheim) (English only) 2015-12-14  
Presentation - Case studies looking at regulatory action and communication – a national experience (Rafe Suvarna) (English only) 2015-12-14  
Presentation - When science and regulatory action meet reality: barriers and critical success factors to managing risk and the salience of trust (Patrick Brown) (English only) 2015-12-14  
Presentation - Strengthening the planning and implementation of risk minimisation (Peter Arlett) (English only) 2015-12-14  
Presentation - When science and regulatory action meet reality: barriers and critical succes factors to managing risk (Peter Mol) (English only) 2015-12-14  
Presentation - Take home messages (June Raine) (English only) 2015-12-14  

Media Videos


Video recording

A video recording is now available. 

To view use the ‘Multimedia’ tab.

Related information